diaziquone has been researched along with Leukocytopenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; van Hazel, GA | 1 |
| Al-Sarraf, M; Ensley, J; Kish, J; Tapazoglou, E | 1 |
| Cascino, TL; Dinapoli, RP; Eagan, RT; O'Fallon, JR; O'Neill, BP; Scheithauer, B | 1 |
| Al-Sarraf, M; Decker, DA; Goldfarb, S; Kish, J | 1 |
| Bramwell, V; Dombernowsky, P; Hansen, HH; Lund, B; Renard, J | 1 |
5 other study(ies) available for diaziquone and Leukocytopenia
| Article | Year |
|---|---|
A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Thrombocytopenia | 1982 |
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vomiting | 1988 |
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
Topics: Adolescent; Adult; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia | 1987 |
Phase II clinical evaluation of AZQ in renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Thrombocytopenia | 1986 |
Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Cystadenocarcinoma; Drug Evaluation; Female; Gastrointestinal Hemorrhage; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Ovarian Neoplasms; Vomiting | 1985 |